CYLD基因改变与HPV阳性头颈癌转移及不良预后相关
研究纳入11例CYLD基因改变的HPV阳性头颈鳞癌患者并分析其临床病程,同时构建一例HPV阳性转移性头颈鳞癌患者来源异种移植模型(PDX)。11例患者均发生转移且总生存期较CYLD野生型转移性HPV阳性患者缩短;该PDX携带CYLD S371*突变并呈连接蛋白43表达降低。结论认为HPV阳性头颈鳞癌中CYLD改变与转移及不良预后相关。
要点
- 11例CYLD改变的HPV阳性头颈鳞癌患者均发生转移,总生存期较CYLD野生型转移患者缩短。
- 转移性PDX携带CYLD S371*突变,连接蛋白43表达降低。
- CYLD改变与HPV阳性头颈鳞癌转移及不良预后相关。
核心结论
- HPV阳性头颈鳞癌中CYLD改变与转移和不良预后相关。
研究设计与样本
- 研究纳入11例CYLD改变的HPV阳性头颈鳞癌患者并评估其临床病程。
- 研究构建并表征一例HPV阳性转移性头颈鳞癌患者来源异种移植模型(PDX)。
- 研究检测了S371*突变及来自11例患者队列中2个CYLD突变的功能影响。
主要发现
- 11例CYLD改变患者均发生转移,总生存期较CYLD野生型转移性HPV阳性患者缩短。
- 转移性PDX携带CYLD S371*突变,连接蛋白43表达降低,连接蛋白43为潜在抗转移蛋白。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human papilloma virus (HPV)-associated head and neck squamous cell carcinoma (HNSCC) is an emerging epidemic and a subset of HPV-positive patients experience aggressive disease with metastases. The CYLD gene is frequently altered in HPV-positive HNSCC, but the role of these alterations in disease progression is poorly understood. METHODS: We identified 11 HPV-positive HNSCC patients with CYLD alterations and assessed their clinical course. We also characterized a unique, HPV-positive, metastatic, HNSCC patient-derived xenograft (PDX). RESULTS: All 11 patients developed metastasis with reduced overall survival when compared with metastatic HPV-positive patients with wild-type CYLD. The metastatic PDX harbored a CYLD mutation (S371*) and exhibited reduced expression of connexin 43, a potentially antimetastatic protein. We also investigated the functional impact of the S371* mutation, as well as 2 CYLD mutations from our 11-patient cohort. CONCLUSION: Our findings indicate that alterations in CYLD in HPV-positive HNSCC are associated with metastasis and poor prognosis.
引用
- Cui Z, Kang H, Li H, et al. CYLD Alterations Are Associated With Metastasis and Poor Prognosis in Human Papilloma Virus-Positive Head and Neck Cancer. Head Neck. 2024. PMID: 39347568. doi:10.1002/hed.27944
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。